NCT00004799View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

April 30, 1991

Conditions
Pertussis
Interventions
BIOLOGICAL

whole-cell pertussis vaccine

BIOLOGICAL

diphtheria-tetanus vaccine

Sponsors
All Listed Sponsors
collaborator

National Bacteriological Laboratory

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH